Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Skin Manifestations of Diabetes | Research article

Diabetes-associated dermatological manifestations in primary care and their association with vascular complications

Authors: Jean-Eudes Trihan, Damien Lanéelle, Neil Metcalfe, Antonia Perez Martin, Pierre Frances

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Introduction

Although type 2 diabetes mellitus (DM) is a global public health problem, the diabetes-associated dermatological (non-infectious) manifestations (DADM) remain poorly understood and under-diagnosed. We aimed to evaluate the prevalence of 7 known DADM in a primary care setting, and their association macro/microvascular complications.

Methods

Cross-sectionnal study included patients consulting in general practice for DM-follow up, from November 2016 to January 2017. Patients aged <18 years old or consulting for other reason than DM follow up were excluded. Each patient were screened for diabetic dermopathy (DD), Huntley’s papules (HP), necrobiosis lipoidica diabeticorum (NL), acanthosis nigricans (AN), cheiroarthropathy (CA, or stiff hand syndrom), scleredema adultorum of Buschke (SB) and bullosis diabeticorum (BD).

Results

213 diabetic patients were included over a period of 3 months. We found a prevalence of 17.8% (38 patients) for DD, 8.5% (18) for HP, 2.8% (6) for NL, 2.3% (5) for AN, 1.9% (4) for CA, 1.4% (3) for SB and 1.4% (3) for BD. DADM seems to be a risk factor for vascular complications (OR 1.97, p ≤ 0.001). Association with vascular involvement was stronger with DD and macroangiopathy (OR 1.86, p ≤ 0.001), and with NL and microangiopathy (OR 9.7, p ≤ 0.001).

Conclusion

In primary care, DM-associated dermatological manifestations present similar prevalence rates to a tertiary care setting, based on litterature. Complete dermatological examination of diabetic patients is essential and could lead to a better overall management of the pathology, as diabetic cutaneous manifestations appear as a sign of vascular involvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organisation. Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World HealthOrganization; 2014. World Health Organisation. Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World HealthOrganization; 2014.
2.
go back to reference World Health Organisation Report on diabetes in the world. 2016 World Health Organisation Report on diabetes in the world. 2016
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.PubMed Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.PubMed
4.
go back to reference Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.PubMedPubMedCentral Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.PubMedPubMedCentral
5.
go back to reference Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377(1):13–27 Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377(1):13–27
6.
go back to reference Trihan J-E, Laneelle D, Perez-Martin A, Metclafe N, Frances P. Prévalence des manifestations cutanées non infectieuses spécifiques du diabète de type 2 en secteur de soins primaires. Médecine. 2018;14(9):401–6. Trihan J-E, Laneelle D, Perez-Martin A, Metclafe N, Frances P. Prévalence des manifestations cutanées non infectieuses spécifiques du diabète de type 2 en secteur de soins primaires. Médecine. 2018;14(9):401–6.
7.
go back to reference Flagothier C, Quatresooz P, Bourguignon R, Piérard-Franchimont C, Piérard GE. Cutaneous Stigmata of Diabetes Mellitus. Rev Med Liege. 2005;60(5‑6):553–9.PubMed Flagothier C, Quatresooz P, Bourguignon R, Piérard-Franchimont C, Piérard GE. Cutaneous Stigmata of Diabetes Mellitus. Rev Med Liege. 2005;60(5‑6):553–9.PubMed
8.
go back to reference Bessis D, Bessis D, Francès C, Guillot B. Diabète sucré. In: Manifestations dermatologiques des maladies d’ organes. Dermatologie et Médecine; 2011. p. 76.1–76.10. Bessis D, Bessis D, Francès C, Guillot B. Diabète sucré. In: Manifestations dermatologiques des maladies d’ organes. Dermatologie et Médecine; 2011. p. 76.1–76.10.
9.
go back to reference Senet P, Chosidow O. Manifestations cutanéomuqueuses du diabète. EMC - Dermatologie. 2011;6(4):1–8. Senet P, Chosidow O. Manifestations cutanéomuqueuses du diabète. EMC - Dermatologie. 2011;6(4):1–8.
10.
go back to reference Françès C. Peau et diabète: a-t-on vraiment avancé? Réalités Thérapeutiques en Dermatologie - Vénérologie. 2014;237:7–12. Françès C. Peau et diabète: a-t-on vraiment avancé? Réalités Thérapeutiques en Dermatologie - Vénérologie. 2014;237:7–12.
11.
go back to reference HAS. Guide de parcours de soins : Diabète de type 2 de l’adulte. 2014 HAS. Guide de parcours de soins : Diabète de type 2 de l’adulte. 2014
12.
go back to reference Von Reutern G-M, Goertler M-W, Bornstein NM, Del Sette M, Evans DH, Hetzel A, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43(3):916–21. Von Reutern G-M, Goertler M-W, Bornstein NM, Del Sette M, Evans DH, Hetzel A, et al. Grading carotid stenosis using ultrasonic methods. Stroke. 2012;43(3):916–21.
13.
go back to reference Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.PubMed Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.PubMed
14.
go back to reference Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–32.PubMed Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–32.PubMed
15.
16.
go back to reference Fournier C, Chabert A, Mosnier-Pudar H, Aujoulat I, Fagot-Campagna A, Gautier A ENTRED Study 2007-2010. 2011 Fournier C, Chabert A, Mosnier-Pudar H, Aujoulat I, Fagot-Campagna A, Gautier A ENTRED Study 2007-2010. 2011
17.
go back to reference Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. BEH. 2008;43(2008):409–13. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. BEH. 2008;43(2008):409–13.
18.
go back to reference Institut de veille sanitaire (France). Prévalence et incidence du diabète, et mortalité liée au diabète en France: synthèse épidémiologique. Saint-Maurice: Institut de veille sanitaire; 2010. Institut de veille sanitaire (France). Prévalence et incidence du diabète, et mortalité liée au diabète en France: synthèse épidémiologique. Saint-Maurice: Institut de veille sanitaire; 2010.
19.
go back to reference Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6.PubMedPubMedCentral Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6.PubMedPubMedCentral
20.
go back to reference Ricci P, Blotière P-O, Weill A, Simon D, Tuppin P, Ricordeau P, et al. Diabète traité: quelles évolutions entre 2000 et 2009 en France. Bull Epidemiol Hebd. 2010;42(43):425–31. Ricci P, Blotière P-O, Weill A, Simon D, Tuppin P, Ricordeau P, et al. Diabète traité: quelles évolutions entre 2000 et 2009 en France. Bull Epidemiol Hebd. 2010;42(43):425–31.
21.
go back to reference Diris N, Colomb M, Leymarie F. Dermatoses non infectieuses au cours du diabète sucré. Ann Dermatol Venereol. 2003;109:1009–14. Diris N, Colomb M, Leymarie F. Dermatoses non infectieuses au cours du diabète sucré. Ann Dermatol Venereol. 2003;109:1009–14.
22.
go back to reference Verny C, Noaillon M, Baudry E. Treatment of Elderly Patients with Type 2 Diabetes Mellitus. Rev Prat. 2015;65(8):1046–9.PubMed Verny C, Noaillon M, Baudry E. Treatment of Elderly Patients with Type 2 Diabetes Mellitus. Rev Prat. 2015;65(8):1046–9.PubMed
23.
go back to reference Fagot-Campagna A, Romon I, Fosse S, Roudier C Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique. Institut de Veille Sanitaire. 2019 Fagot-Campagna A, Romon I, Fosse S, Roudier C Prévalence et incidence du diabète, et mortalité liée au diabète en France. Synthèse épidémiologique. Institut de Veille Sanitaire. 2019
24.
go back to reference McCash S, Emanuel PO. Defining diabetic dermopathy: Defining diabetic dermopathy. J Dermatol. 2011;38(10):988–92.PubMed McCash S, Emanuel PO. Defining diabetic dermopathy: Defining diabetic dermopathy. J Dermatol. 2011;38(10):988–92.PubMed
25.
go back to reference Melin H. An Atrophic Circumcised Skin Lesion In The Lower Extremities Of Diabetics. Acta Med Scand. 1964;176(Suppl 423):1–75. Melin H. An Atrophic Circumcised Skin Lesion In The Lower Extremities Of Diabetics. Acta Med Scand. 1964;176(Suppl 423):1–75.
26.
go back to reference Huntley AC. Finger pebbles: A common finding in diabetes mellitus. J Am Acad Dermatol. 1986;14(4):612–7.PubMed Huntley AC. Finger pebbles: A common finding in diabetes mellitus. J Am Acad Dermatol. 1986;14(4):612–7.PubMed
27.
go back to reference Fitzgibbons PG, Weiss A-PC. Hand Manifestations of Diabetes Mellitus. J Hand Surg. 2008;33(5):771–5. Fitzgibbons PG, Weiss A-PC. Hand Manifestations of Diabetes Mellitus. J Hand Surg. 2008;33(5):771–5.
28.
go back to reference Peyrí J, Moreno A, Marcoval J. Necrobiosislipoidica. Semin Cutan Med Surg. 2007;26(2):87–9.PubMed Peyrí J, Moreno A, Marcoval J. Necrobiosislipoidica. Semin Cutan Med Surg. 2007;26(2):87–9.PubMed
29.
go back to reference Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking and proteinuria. A case controlled study. Diabet Med. 1993;10(8):725–8.PubMed Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking and proteinuria. A case controlled study. Diabet Med. 1993;10(8):725–8.PubMed
30.
go back to reference Rafalson L, Pham TH, Willi SM, Marcus M, Jessup A, Baranowski T. The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade students. Obesity. 2013;21(3):E328–33.PubMed Rafalson L, Pham TH, Willi SM, Marcus M, Jessup A, Baranowski T. The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade students. Obesity. 2013;21(3):E328–33.PubMed
31.
go back to reference Karadağ AS, You Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36(1):48–53.PubMed Karadağ AS, You Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36(1):48–53.PubMed
32.
go back to reference Humbert P, Nguyen N. Physiopathology of acanthosis nigricans. Ann Dermatol Venereol. 1998;125(11):851–5.PubMed Humbert P, Nguyen N. Physiopathology of acanthosis nigricans. Ann Dermatol Venereol. 1998;125(11):851–5.PubMed
33.
go back to reference De Schepper S, Naeyaert J-M. Acanthosis Nigricans. Encyclopédie Médico Chirurgicale. 2006 De Schepper S, Naeyaert J-M. Acanthosis Nigricans. Encyclopédie Médico Chirurgicale. 2006
34.
go back to reference Cabo HA. Thick skin syndrome in diabetes mellitus. J Eur Acad Dermatol Venereol. 2000;14(2):143–4.PubMed Cabo HA. Thick skin syndrome in diabetes mellitus. J Eur Acad Dermatol Venereol. 2000;14(2):143–4.PubMed
35.
go back to reference Riad H, Al Ansari H, Mansour K, Al Mannai H, Al Sada H, Abu Shaikha S, et al. Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female, Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female. Case Reports in Dermatological Medicine, Case Reports in Dermatological Medicine 2013; 2013:e641416. Riad H, Al Ansari H, Mansour K, Al Mannai H, Al Sada H, Abu Shaikha S, et al. Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female, Pruritic Vesicular Eruption on the Lower Legs in a Diabetic Female. Case Reports in Dermatological Medicine, Case Reports in Dermatological Medicine 2013; 2013:e641416.
36.
go back to reference Mohanty KC, Singh R, Lyengar B. Bullosis Diabeticorum. Indian J Dermatol Venereol Leprol. 1979;45(2):119–21.PubMed Mohanty KC, Singh R, Lyengar B. Bullosis Diabeticorum. Indian J Dermatol Venereol Leprol. 1979;45(2):119–21.PubMed
37.
go back to reference Ghosh S, Bandyopadhyay D, Chatterjee G. Bullosisdiabeticorum: a distinctive blistering eruption in diabetes mellitus. Int J Diabetes Dev Ctries. 2009;29(1):41.PubMedPubMedCentral Ghosh S, Bandyopadhyay D, Chatterjee G. Bullosisdiabeticorum: a distinctive blistering eruption in diabetes mellitus. Int J Diabetes Dev Ctries. 2009;29(1):41.PubMedPubMedCentral
38.
go back to reference Cole GW, Headley J, Skowsky R. Scleredema Diabeticorum: A Common and Distinct Cutaneous Manifestation of Diabetes Mellitus. Diabetes Care. 1983;6(2):189–92.PubMed Cole GW, Headley J, Skowsky R. Scleredema Diabeticorum: A Common and Distinct Cutaneous Manifestation of Diabetes Mellitus. Diabetes Care. 1983;6(2):189–92.PubMed
39.
go back to reference Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013;42(4):869–98.PubMed Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013;42(4):869–98.PubMed
40.
go back to reference Sattar MA, Diab S, Sugathan TN, Sivanandasingham P, Fenech FF. Scleroedema Diabeticorum: a Minor but Often Unrecognized Complication of Diabetes Mellitus. Diabet Med. 1988;5(5):465–8.PubMed Sattar MA, Diab S, Sugathan TN, Sivanandasingham P, Fenech FF. Scleroedema Diabeticorum: a Minor but Often Unrecognized Complication of Diabetes Mellitus. Diabet Med. 1988;5(5):465–8.PubMed
41.
go back to reference Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.PubMed Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.PubMed
42.
go back to reference Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease an update. Hypertension. 2001;37(4):1053–9.PubMed Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease an update. Hypertension. 2001;37(4):1053–9.PubMed
43.
go back to reference Boursier V, Lazareth I, Pernes J-M, Dadon M, Priollet P. Artériopathie du diabétique : les clés de la prise en charge. Sang Thrombose Vaisseaux. 2001;13(10):599–607. Boursier V, Lazareth I, Pernes J-M, Dadon M, Priollet P. Artériopathie du diabétique : les clés de la prise en charge. Sang Thrombose Vaisseaux. 2001;13(10):599–607.
44.
go back to reference Houck GM, Morgan MB. A reappraisal of the histologicfindings of pigmented pretibial patches of diabetes mellitus. J Cutan Pathol. 2004;31(2):141–4.PubMed Houck GM, Morgan MB. A reappraisal of the histologicfindings of pigmented pretibial patches of diabetes mellitus. J Cutan Pathol. 2004;31(2):141–4.PubMed
45.
go back to reference Barrett SC, Huffman FG, Johnson P, Campa A, Magnus M, Ragoobirsingh D. A cross-sectionalstudy of Jamaican adolescents’ risk for type 2 diabetes and cardiovascular diseases. BMJ Open. 2013;3(7). Barrett SC, Huffman FG, Johnson P, Campa A, Magnus M, Ragoobirsingh D. A cross-sectionalstudy of Jamaican adolescents’ risk for type 2 diabetes and cardiovascular diseases. BMJ Open. 2013;3(7).
46.
go back to reference Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015;33(3):343–60.PubMed Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015;33(3):343–60.PubMed
47.
go back to reference Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.PubMed Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995;12(3):220–3.PubMed
48.
go back to reference Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited Joint Mobility in Childhood Diabetes Mellitus Indicates Increased Risk for MicrovascularDisease. N Engl J Med. 1981;305(4):191–4.PubMed Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited Joint Mobility in Childhood Diabetes Mellitus Indicates Increased Risk for MicrovascularDisease. N Engl J Med. 1981;305(4):191–4.PubMed
49.
go back to reference Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, et al. The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications. Diabetes Care. 1998;21(4):506–9.PubMed Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, et al. The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications. Diabetes Care. 1998;21(4):506–9.PubMed
50.
go back to reference Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clin Diabetes. 2015;33(1):40–8.PubMedPubMedCentral Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clin Diabetes. 2015;33(1):40–8.PubMedPubMedCentral
51.
go back to reference George SM, Walton S. Diabetic dermopathy. Br J Diabetes. 2014;14(3):95. George SM, Walton S. Diabetic dermopathy. Br J Diabetes. 2014;14(3):95.
52.
go back to reference Mekić S, Jacobs LC, Gunn DA, Mayes AE, Ikram MA, Pardo LM, et al. Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study. J Am Acad Dermatol. 2019;81(4):963–969.e2.PubMed Mekić S, Jacobs LC, Gunn DA, Mayes AE, Ikram MA, Pardo LM, et al. Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study. J Am Acad Dermatol. 2019;81(4):963–969.e2.PubMed
53.
go back to reference Piérard GE, Piérard-Franchimont C, Scheen A. Critical assessment of diabetic xerosis. Expert Opinion on Medical Diagnostics. 2013;7(2):201–7.PubMed Piérard GE, Piérard-Franchimont C, Scheen A. Critical assessment of diabetic xerosis. Expert Opinion on Medical Diagnostics. 2013;7(2):201–7.PubMed
Metadata
Title
Diabetes-associated dermatological manifestations in primary care and their association with vascular complications
Authors
Jean-Eudes Trihan
Damien Lanéelle
Neil Metcalfe
Antonia Perez Martin
Pierre Frances
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00594-1

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.